Potent Neuropeptide Y Y, Receptor Antagonist, 1229U91: Blockade
... [Leu3’,Pro34]NPY, indicating that Y, receptors are predominant in this region. This result is consistent with other reports (34-37). However, we did not detect Y, receptors in the hypothalamus in these experiments, although it has been suggested that NPY-induced food intake is mediated via Y,-type r ...
... [Leu3’,Pro34]NPY, indicating that Y, receptors are predominant in this region. This result is consistent with other reports (34-37). However, we did not detect Y, receptors in the hypothalamus in these experiments, although it has been suggested that NPY-induced food intake is mediated via Y,-type r ...
Diversity of Class I HLA Molecules: Functional and
... In the past 5 years, the nature of major histocompatibility complex (MHC) glycoproteins, as well as the mechanism by which they restrict antigen recognition by T lymphocytes, has been clarified. These molecules bind peptides within intracellular membrane compartments, forming complexes that are then ...
... In the past 5 years, the nature of major histocompatibility complex (MHC) glycoproteins, as well as the mechanism by which they restrict antigen recognition by T lymphocytes, has been clarified. These molecules bind peptides within intracellular membrane compartments, forming complexes that are then ...
Differential Internalization of the Prostaglandin F2α Receptor
... 1997). These two isoforms are generated by alternative mRNA splicing that gives rise to differences in their intracellular carboxyl-terminal domain. Studies on these receptor isoforms have demonstrated that upon stimulation with PGF2␣ more than one signaling pathway can be activated. Thus, stimulati ...
... 1997). These two isoforms are generated by alternative mRNA splicing that gives rise to differences in their intracellular carboxyl-terminal domain. Studies on these receptor isoforms have demonstrated that upon stimulation with PGF2␣ more than one signaling pathway can be activated. Thus, stimulati ...
Introduced amino terminal epitopes can reduce surface expression
... α4 or β4 subunits, the V5 epitope has little effect when placed in either, while the Myc epitope reduces expression more when inserted into β4 than α4. These results indicate that the extreme amino terminal region is important for assembly of these receptors, and demonstrate that some widely used in ...
... α4 or β4 subunits, the V5 epitope has little effect when placed in either, while the Myc epitope reduces expression more when inserted into β4 than α4. These results indicate that the extreme amino terminal region is important for assembly of these receptors, and demonstrate that some widely used in ...
ATP as a Signaling Molecule: the Exocrine Focus
... the case of a pore formation, ATP then becomes the killing molecule, causing necrosis or apoptosis in cells expressing P2X7 and being exposed to ATP, often at relatively high concentrations, and aggravated by altered ionic composition or pH. However, in its more peaceful edition the P2X7 receptor ma ...
... the case of a pore formation, ATP then becomes the killing molecule, causing necrosis or apoptosis in cells expressing P2X7 and being exposed to ATP, often at relatively high concentrations, and aggravated by altered ionic composition or pH. However, in its more peaceful edition the P2X7 receptor ma ...
The NK2.1 receptor is encoded by Ly-49C and its
... cell-mediated lysis. In the C57BL/6 mouse, the NK1.1 molecule acts as an activation receptor whereas Ly-49A, C and G2 can inhibit NK cell lysis of target cells expressing specific MHC class I molecules. We previously reported that NK2.1 is an activation receptor sharing structural properties with me ...
... cell-mediated lysis. In the C57BL/6 mouse, the NK1.1 molecule acts as an activation receptor whereas Ly-49A, C and G2 can inhibit NK cell lysis of target cells expressing specific MHC class I molecules. We previously reported that NK2.1 is an activation receptor sharing structural properties with me ...
- Wiley Online Library
... The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target ...
... The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target ...
Receptor Activation and Homer Differentially Control the Lateral
... Nusser et al., 1994; Vidnyánszky et al., 1994). This localization is not stringent, because up to 75% of mGluR1/5 are found at nonsynaptic sites (Lujan et al., 1997). Concentration of mGluR1/5 at synaptic sites likely results from an equilibrium between synaptic and extrasynaptic receptors through ...
... Nusser et al., 1994; Vidnyánszky et al., 1994). This localization is not stringent, because up to 75% of mGluR1/5 are found at nonsynaptic sites (Lujan et al., 1997). Concentration of mGluR1/5 at synaptic sites likely results from an equilibrium between synaptic and extrasynaptic receptors through ...
Slide 1
... The concentration of hormone as seen by target cells is determined by three factors: (cont.) 2-Rate of delivery: An example of this effect is blood flow to a target organ or group of target cells – high blood flow delivers more hormone than low blood flow. 3-Rate of degradation and elimination: ...
... The concentration of hormone as seen by target cells is determined by three factors: (cont.) 2-Rate of delivery: An example of this effect is blood flow to a target organ or group of target cells – high blood flow delivers more hormone than low blood flow. 3-Rate of degradation and elimination: ...
Lecture 1 - Hormone Action
... In order to initiate their biologic effects, target cells must recognize hormones by binding to specific receptors A target cell is defined by its ability to bind selectively a given hormone via a receptor Receptors have at least 2 DOMAINS: 1- Recognition domain: binds to the hormone 2- Coupling dom ...
... In order to initiate their biologic effects, target cells must recognize hormones by binding to specific receptors A target cell is defined by its ability to bind selectively a given hormone via a receptor Receptors have at least 2 DOMAINS: 1- Recognition domain: binds to the hormone 2- Coupling dom ...
Membrane receptors in the gastrointestinal tract
... p21 protein encoded by the ras oncogene of Harvey murine sarcoma virus v-Ha-ras (31). These systems play a very important part in the differentiation and cell growth processes in eukaryotes. Thus, PDGF (platelet-derived growth factor) is a 30KDa protein made up of 2 polypeptidic chains: A, encoded o ...
... p21 protein encoded by the ras oncogene of Harvey murine sarcoma virus v-Ha-ras (31). These systems play a very important part in the differentiation and cell growth processes in eukaryotes. Thus, PDGF (platelet-derived growth factor) is a 30KDa protein made up of 2 polypeptidic chains: A, encoded o ...
Molecular Cloning and Pharmacological Characterization of a
... The predicted protein (638 amino acids) shows the typical seven hydrophobic regions putatively forming the seven TM domains characteristic for G protein-coupled receptors. An eighth hydrophobic region at the amino-terminal part of the protein, as is present in many invertebrate G protein-coupled neu ...
... The predicted protein (638 amino acids) shows the typical seven hydrophobic regions putatively forming the seven TM domains characteristic for G protein-coupled receptors. An eighth hydrophobic region at the amino-terminal part of the protein, as is present in many invertebrate G protein-coupled neu ...
Pharmacological Characterization and Identification of Amino Acids
... binding studies, and mutagenesis reports have shown that the large N-terminal extracellular domain of mGlu receptors contains the glutamate binding or orthosteric site (Kunishima et al., 2000). The allosteric modulation of ligand-gated ion channels is a well-known phenomenon and has been exploited t ...
... binding studies, and mutagenesis reports have shown that the large N-terminal extracellular domain of mGlu receptors contains the glutamate binding or orthosteric site (Kunishima et al., 2000). The allosteric modulation of ligand-gated ion channels is a well-known phenomenon and has been exploited t ...
5.3 G Protein-Coupled Receptors
... sites for carbohydrate residues, are also located nearby in the extracellular domain. The extracellular localized protein portion may be formed from a continuous protein chain and may include several hundred amino acids. If the receptor crosses the membrane with several transmembrane segments, the ...
... sites for carbohydrate residues, are also located nearby in the extracellular domain. The extracellular localized protein portion may be formed from a continuous protein chain and may include several hundred amino acids. If the receptor crosses the membrane with several transmembrane segments, the ...
Negative regulation of oncogenic signaling by receptor tyrosine
... suggests that negative circuits were added to the network relatively late in evolution, and they exhibit unexpected variation and complexity. Concentrating on negative mechanisms, we found that ligand-induced endocytosis and degradation of active receptors is a major regulatory pathway involving not ...
... suggests that negative circuits were added to the network relatively late in evolution, and they exhibit unexpected variation and complexity. Concentrating on negative mechanisms, we found that ligand-induced endocytosis and degradation of active receptors is a major regulatory pathway involving not ...
GABRA1 (gamma-aminobutyric acid (GABA) A receptor. alpha 1
... Disease: Defects in GABRA1 are a cause of juvenile myoclonic epilepsy (JME) [MIM:606904]. JME is a common epileptic syndrome characterized by afebrile seizures, onset in adolescence (rather than in childhood) and myoclonic jerks. Disease: Defects in GABRA1 are the cause of childhood absence epilepsy ...
... Disease: Defects in GABRA1 are a cause of juvenile myoclonic epilepsy (JME) [MIM:606904]. JME is a common epileptic syndrome characterized by afebrile seizures, onset in adolescence (rather than in childhood) and myoclonic jerks. Disease: Defects in GABRA1 are the cause of childhood absence epilepsy ...
MECHANISMS OF INTERCELLULAR COMMUNICATION
... • http://www.vivo.colostate.edu/hbooks/path phys/endocrine/index.html • http://www.uri.edu/pharmacy/animation/hu angAnim.htm • http://www.infochembio.ethz.ch/links/en/bi ochem_hormone.html • http://www.scientia.org/cadonline/Biology/e ndocrine/action.ASP ...
... • http://www.vivo.colostate.edu/hbooks/path phys/endocrine/index.html • http://www.uri.edu/pharmacy/animation/hu angAnim.htm • http://www.infochembio.ethz.ch/links/en/bi ochem_hormone.html • http://www.scientia.org/cadonline/Biology/e ndocrine/action.ASP ...
ß-arrestin signaling and regulation of transcription
... the phosphorylated receptor is an important facet of GPCR signaling (Reiter and Lefkowitz, 2006). The arrestin family consists of four members. Visual arrestins (arrestin 1 and arrestin 4) are expressed almost exclusively in the retina (Kuhn, 1978). -arrestin 1 and arrestin 2 (non-visual arrestins ...
... the phosphorylated receptor is an important facet of GPCR signaling (Reiter and Lefkowitz, 2006). The arrestin family consists of four members. Visual arrestins (arrestin 1 and arrestin 4) are expressed almost exclusively in the retina (Kuhn, 1978). -arrestin 1 and arrestin 2 (non-visual arrestins ...
Transcription factors
... RXR is a common partner in >10 different pathways – can be silent (non-permissive) – can be active (permissive) – offers another means to regulate dimeric receptors • rexinoids (RXR selective compounds) are being used clinically in treatment of diabetes, breast cancer and other diseases. – at least ...
... RXR is a common partner in >10 different pathways – can be silent (non-permissive) – can be active (permissive) – offers another means to regulate dimeric receptors • rexinoids (RXR selective compounds) are being used clinically in treatment of diabetes, breast cancer and other diseases. – at least ...
Cellular Receptors and Signal Transduction in Molluscan
... SYNOPSIS. The involvement of circulating hemocytes as the principal cellular effector mediating molluscan immune responses is well established. They participate in a variety of internal defense-related activities including microbial phagocytosis, multicellular encapsulation, and cell-mediated cytoto ...
... SYNOPSIS. The involvement of circulating hemocytes as the principal cellular effector mediating molluscan immune responses is well established. They participate in a variety of internal defense-related activities including microbial phagocytosis, multicellular encapsulation, and cell-mediated cytoto ...
"Neurotransmitter Receptors in the Postsynaptic Neuron". In
... receptors are the largest family of neurotransmitter receptor. The prototype is the b-adrenergic receptor, which itself has structural (but not amino acid sequence!) homology to the protein bacteriorhodopsin, and homology with rhodopsin, the light-harvesting protein expressed in the eye. Metabotropi ...
... receptors are the largest family of neurotransmitter receptor. The prototype is the b-adrenergic receptor, which itself has structural (but not amino acid sequence!) homology to the protein bacteriorhodopsin, and homology with rhodopsin, the light-harvesting protein expressed in the eye. Metabotropi ...
Chapter 16
... Growth factors are proteins that play important roles in regulating cell differentiation, division, and movement. Activating mutations in growth factor receptors or their signaling pathways commonly are associated with cancers. Transforming growth factor ß (TGFß) plays widespread roles in regulating ...
... Growth factors are proteins that play important roles in regulating cell differentiation, division, and movement. Activating mutations in growth factor receptors or their signaling pathways commonly are associated with cancers. Transforming growth factor ß (TGFß) plays widespread roles in regulating ...
Diabetes & The Endocannabinoid System: Prospects For
... and insulin secretion in pancreatic β-cells”. Cell Calcium 39: 155-162. Kalia, K., et al. 2004. “Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy”. Clinica Chimica Acta 347: 169-176. Li, X., et al. 2001. “Examination of the immunosuppressive effect of delta-9-THC in streptozoto ...
... and insulin secretion in pancreatic β-cells”. Cell Calcium 39: 155-162. Kalia, K., et al. 2004. “Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy”. Clinica Chimica Acta 347: 169-176. Li, X., et al. 2001. “Examination of the immunosuppressive effect of delta-9-THC in streptozoto ...
Adenosine
... protein phosphatase (type 2B) 2. serine:threonine-specific protein phosphatases 3. target of the immunosuppressant drugreceptor ...
... protein phosphatase (type 2B) 2. serine:threonine-specific protein phosphatases 3. target of the immunosuppressant drugreceptor ...
Redistribution of Mannose-6-Phosphate Receptors Induced by
... punctate intracellular staining was seen which was concentrated in the juxtanuclear or Golgi region (Fig. 1 B) . In cells treated with tunicamycin (Fig. 1 C) or cycloheximide (Fig. 1 D), no morphological changes were detected by phase-contrast microscopy. By immunofluorescence the receptors were see ...
... punctate intracellular staining was seen which was concentrated in the juxtanuclear or Golgi region (Fig. 1 B) . In cells treated with tunicamycin (Fig. 1 C) or cycloheximide (Fig. 1 D), no morphological changes were detected by phase-contrast microscopy. By immunofluorescence the receptors were see ...